Mayne Pharma Group Ltd
ASX:MYX
Mayne Pharma Group Ltd
ASX:MYX
Price:
7.12 AUD
-0.28%
Market Closed
Updated:
May 10, 2024
Cash Flow Statement
Cash Flow Statement
Mayne Pharma Group Ltd
Mayne Pharma Group Ltd
Currency: AUD
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | ||
|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||
| Cash Taxes Paid |
(3)
|
7
|
4
|
(4)
|
(0)
|
|
| Change in Working Capital |
(23)
|
(32)
|
(63)
|
(39)
|
(0)
|
|
| Cash from Operating Activities |
13
N/A
|
(7)
N/A
|
(64)
-794%
|
(43)
+34%
|
(15)
+66%
|
|
| Investing Cash Flow | ||||||
| Capital Expenditures |
(20)
|
(12)
|
(223)
|
(220)
|
(19)
|
|
| Other Items |
(23)
|
(17)
|
685
|
693
|
82
|
|
| Cash from Investing Activities |
(43)
N/A
|
(29)
+34%
|
462
N/A
|
473
+2%
|
63
-87%
|
|
| Financing Cash Flow | ||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
(6)
|
(17)
|
|
| Net Issuance of Debt |
18
|
37
|
(331)
|
(376)
|
(51)
|
|
| Cash Paid for Dividends |
0
|
0
|
0
|
(45)
|
0
|
|
| Other |
(11)
|
(9)
|
(6)
|
(5)
|
1
|
|
| Cash from Financing Activities |
7
N/A
|
28
+313%
|
(338)
N/A
|
(432)
-28%
|
(113)
+74%
|
|
| Change in Cash | ||||||
| Effect of Foreign Exchange Rates |
7
|
7
|
1
|
(3)
|
(1)
|
|
| Net Change in Cash |
(17)
N/A
|
(1)
+92%
|
61
N/A
|
(4)
N/A
|
(66)
-1 535%
|
|
| Free Cash Flow | ||||||
| Free Cash Flow |
(7)
N/A
|
(19)
-188%
|
(287)
-1 406%
|
(262)
+9%
|
(34)
+87%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
